ZSCAN1 and breast carcinoma: In this study, we found that ZSCAN1 is a novel tumor suppressor, which is suppressed in breast cancer cells and predicts a better prognosis of breast cancer patients (Figure 1); its suppression increased the tumorigenicity and stemness properties of breast cancer cells (Figures 1–3).